Serum isoflavones and lignans and odds of breast cancer in pre- and postmenopausal Chinese women

• Published in: Menopause (New York, N.Y.) Vol. 28; no. 4; p. 413
• Main Authors: Feng, Xiao-Li, Ho, Suzanne C, Zhan, Xiao-Xia, Zuo, Luo-Shi-Yuan, Mo, Xiong-Fei, Zhang, Xin, Abulimiti, Alinuer, Huang, Chu-Yi, Zhang, Cai-Xia
• Format: Journal Article
• Language: English
• Published: United States 01.04.2021
• Subjects: Breast Neoplasms - epidemiology; Breast Neoplasms - prevention & control; Case-Control Studies; China - epidemiology; Female; Humans; Isoflavones; Lignans; Postmenopause; China
• ISSN: 1530-0374
• DOI: 10.1097/GME.0000000000001715

Isoflavones and lignans are phytoestrogens present in plant-based foods, which have a potential preventive effect on breast carcinogenesis. The effects of phytoestrogens on breast cancer may differ according to the hormonal environment. This case-control study aimed to investigate the association between serum phytoestrogens and odds of breast cancer among Chinese pre- and postmenopausal women. A total of 792 cases and 813 age-matched controls were included. Serum isoflavone (daidzein, genistein, glycitein, equol, and formononetin) and lignan (enterodiol and enterolactone) concentrations were measured using a liquid chromatography-tandem mass spectrometry method. Significant inverse associations were found between serum total soy isoflavone precursors, daidzein, genistein, formononetin, total lignans, enterodiol, enterolactone, and the odds of breast cancer in premenopausal but not postmenopausal women. For premenopausal women, the adjusted odds ratios (95% confidence intervals) for the highest versus the lowest serum concentration groups were 0.60 (0.41-0.87) for total soy isoflavones precursors, 0.64 (0.44-0.93) for daidzein, 0.62 (0.43-0.90) for genistein, 0.49 (0.35-0.68) for formononetin, 0.38 (0.25-0.57) for total lignans, 0.49 (0.33-0.73) for enterodiol, and 0.49 (0.33-0.74) for enterolactone. However, the interaction between serum phytoestrogens and menopausal status on odds of breast cancer was statistically significant only for daidzein. No significant association was found between serum equol or gycitein and the odds of breast cancer among either pre- or postmenopausal women. Higher levels of certain serum isoflavones and lignans were associated with reduced odds of breast cancer in premenopausal women, but the interaction was statistically significant only for daidzein.